K

Kezar Life Sciences

80 employees

Kezar Life Sciences company focused on the discovery and development of drugs targeting protein homeostasis for autoimmune disorders

Basic info

Industry

biotechnology research

Sectors

Autoimmune Disease
Health Diagnostics
Biotechnology
Health Care
Immunology
Therapeutics
Oncology
Drug Development
Drug Discovery
Life Science

Date founded

2015

Funding rounds raised

Total raised

$50M

from 11 investors over 11 rounds

K

Kezar Life Sciences raised $50M on November 10, 2021

Investors: Oxford Finance LLC

K

Kezar Life Sciences raised $50M on July 25, 2017

Investors: Chiesi Ventures, Omega Funds, Bay City Capital, AJU IB INVESTMENT, Qiming Venture Partners, Pappas Ventures and Cowen Inc.

K

Kezar Life Sciences raised $23M on June 5, 2015

Investors: KittyHawk Ventures, Omega Funds and AJU IB INVESTMENT

FAQ